G Nalbone
Overview
Explore the profile of G Nalbone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lairon D, Nalbone G, Domingo N, Lafont H, Hauton J, Julien R, et al.
Lipids
. 2016 Aug;
10(4):262-5.
PMID: 27521077
Lipase and colipase were prepared separately from rat pancreatic juice, and their respective interaction with biliary lipids was investigated by gel filtration on agarose in the presence of a micellar...
2.
Morange P, Tregouet D, Godefroy T, Saut N, Bickel C, Rupprecht H, et al.
J Mol Med (Berl)
. 2008 Jul;
86(10):1153-61.
PMID: 18600307
Tumor necrosis factor (TNF) is a major cytokine involved in inflammatory reaction and a mortality predictor in patients with coronary artery disease (CAD). Plasma levels of soluble TNF (sTNF) depend...
3.
Canault M, Peiretti F, Poggi M, Mueller C, Kopp F, Bonardo B, et al.
J Pathol
. 2008 Feb;
214(5):574-83.
PMID: 18247429
TNFalpha (TNF) critically regulates inflammation-driven atherosclerosis. Because the transmembrane (tmTNF) and soluble (sTNF) forms of TNF possess distinct immuno-modulatory properties, we hypothesized that they might differentially regulate atherosclerosis progression. Three...
4.
Nalbone G, Bernot D, Peiretti F, Alessi M
Arch Mal Coeur Vaiss
. 2003 May;
96(3):207-13.
PMID: 12722551
Inhibitors of HMG-CoA reductase (statins) lower the level of circulating LDL-C by blocking the activity of HMG-CoA reductase. Their efficiency to prevent cardiovascular events was demonstrated in several clinical trials...
5.
Peiretti F, Lopez S, Bonardo B, Juhan-Vague I, Nalbone G
J Biol Chem
. 2001 Jun;
276(34):32214-9.
PMID: 11402043
We investigated intracellular mechanisms involved in the up-regulation of plasminogen activator inhibitor I (PAI-1) synthesis by human recombinant tumor necrosis factor-alpha (TNF) during monocyte differentiation of HL-60 cells triggered by...
6.
Lopez S, Peiretti F, Bonardo B, Laouenan H, Juhan-Vague I, Nalbone G
J Cardiovasc Pharmacol
. 2001 Jun;
37(6):762-8.
PMID: 11392473
The fibrinolytic inhibitor plasminogen activator inhibitor type 1 (PAI-1) plays a role in the development of atherothrombosis and is produced by macrophages that infiltrate the atherosclerotic vessel wall. Because statins...
7.
Lopez S, Peiretti F, Bonardo B, Juhan-Vague I, Nalbone G
Atherosclerosis
. 2000 Sep;
152(2):359-66.
PMID: 10998463
Inhibitors of HMG-CoA reductase, namely statins, improve endothelial function independently of their cholesterol-lowering effects. Plasminogen activator inhibitor type-1 (PAI-1) plays a critical role in vascular pathophysiology both at the intra-...
8.
Lopez S, Peiretti F, Bonardo B, Juhan-Vague I, Nalbone G
J Biol Chem
. 2000 Feb;
275(5):3081-7.
PMID: 10652289
Tumor necrosis factor-alpha (TNFalpha) critically regulates several cellular functions during monocyte/macrophage differentiation. We therefore investigated during the phorbol ester (phorbol 12-myristate 13-acetate (PMA))-induced monocyte/macrophage differentiation of the human HL-60 leukemia...
9.
Lopez S, Peiretti F, Morange P, Laouar A, Fossat C, Bonardo B, et al.
Thromb Haemost
. 1999 Apr;
81(3):415-22.
PMID: 10102471
HL-60 cells treated by PMA develop the monocyte adherent phenotype and synthesize plasminogen activator inhibitor type-1 (PAI-1). We focused our study on the identification of the PMA-activated protein kinase C...
10.
Peiretti F, Alessi M, Henry M, Anfosso F, Juhan-Vague I, Nalbone G
Arterioscler Thromb Vasc Biol
. 1997 Aug;
17(8):1550-60.
PMID: 9301635
We investigated in human umbilical vein endothelial cells (HUVECs) the interaction between the signaling pathways triggered by calcium mobilization and those affected by human recombinant tumor necrosis factor-alpha (TNF) on...